Uploads
Contact
/
Login
Upload
Search Results for 'Nsclc'
Raising the Bar in the Management of Advanced/Metastatic NSCLC
debby-jeon
Antiangiogenic Agents in Advanced NSCLC
ellena-manuel
Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
stefany-barnette
EGFR-Mutated Advanced NSCLC
sherrill-nordquist
The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature
stefany-barnette
James Yang,
pasty-toler
David R.
alida-meadow
Thierry
cheryl-pisano
Michael
luanne-stotts
Using Non-targeted Therapies in Targeted Lung Cancer Popula
ellena-manuel
MEK Inhibitors and their potential role in relapsed NSCLC
debby-jeon
Comparision
jane-oiler
The Role of Antiangiogenic Agents
luanne-stotts
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
pasty-toler
NSCLC with high PD-L1 expression on tumor cells or tumor-in
test
ASCO 2019 NSCLC - PARP & Chemotherapy
mitsue-stanley
Italian cohort of
test
Minesh Mehta, Northwestern University
mitsue-stanley
Slides last updated:
stefany-barnette
Slides last updated:
calandra-battersby
Integration of Immunotherapy Across
karlyn-bohler
Integration of Immunotherapy Across
pamella-moone
Terapia
min-jolicoeur
Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%
olivia-moreira
1
2
3
4
5
6